Clinical use of afala in the therapy of chronic prostatitis.

Abstract

The efficiency of afala in the therapy of chronic abacterial prostatitis was demonstrated. The preparation considerably improved urodynamics, reduced pain syndrome and inflammation, decreased prostate volume, improved patient's quality of life, and restored microcirculation in the prostate. No changes in blood, urine, and ECG parameters were noted. No side effects requiring afala withdrawal were recorded.

• Authors: V N Tkachuk
• Journal: Bulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 148 Issue 2 Pg. 312-4 (Aug 2009) ISSN: 1573-8221 [Electronic] United States
• PMID: 20027356 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Antibodies
• Immunologic Factors
• afala

Topics

• Adult
• Antibodies (pharmacology, therapeutic use)
• Chronic Disease
• Humans
• Immunologic Factors (pharmacology, therapeutic use)
• Inflammation (drug therapy, pathology)
• Male
• Middle Aged
• Prostatitis (drug therapy, immunology, pathology)
• Treatment Outcome
• Urodynamics (drug effects)
• Young Adult